Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed and will come very very strong
I completely agree 2 presentations tomorrow hoping for a recovery!
NO ACCESS TO STOCK SEASONALITY SIGNED UP ON SATURDAY HELP! Its annoying there is no contact us button!
just need the login instructions so I can get into the chatroom
hey chartinator I still haven't received my password for stock seasonality can you please send it to me I payed for it on saturday
Thanks
yes I would love to join you in room but don't have login or password. I am wondering if you can email that to me. By the way yes that is the email
thanks
Signed up for stock seasonality on Sunday but haven't heard anything yet. Please set up my account I would like if possible to be up and running for tomorrow with any stocks on watch list for sunday..
Thanks
I signed up and payed through paypal....
Would love to if I had an inkling we would be moving in the right direction down about 78% at this point I am not going to throw good money onto this thing which has been a disaster for my portfolio....
Just hoping I break even some day
Update down from 1.23 avg after having averaged down... Is this going to be a loser?
Alrighty... I guess now is the time to average down.... Hoping for the best
BANR Looks primed to go today. Anyone have any opinions...
Yes... BS trade that makes account go down 75% on 100 shares... that is BS
Put my sell in at 4.00 scottrade won't let me put it higher then that
yes lets keep running this up please to where its suppose to be
Datpiff in the hood.....
Wow. Hate mail Blue. That is just so not right. Were you sitting there clicking the buy button for them too? Anyhow. I am holding all my shares here waiting for the big move. I think its acceptable to express frustration on the message board when a stock that some bought at 1.40's 2.00 range is at .30 cents. It is stressful but What is important is to only invest money that you can and don't throw your lifesavings here. I personally invested in it and have been sitting on it for a while and waiting for a significant move upwards. Hoping we get it soon...
All the best and hope you are right to 2 dollar land!
your welcome to have mine at 1.50 a share
added more at .33 for avg of 1.24 now instead of 1.42 waiting for dollars and it is coming....... just have to bear with the BS!
gave me 500 at .32 even though i had it at ask of .33 and it shows as 5000 shares instead of 500..
confused
had a buy order at .33 since open at the ask doesn't want to take it hmmm....
Yes. well from 1.40's and some higher then that to .35 cents that is what is called major bagholder in a day... waiting patiently for it to move up but I just don't see it going to the 2-3 bucks forecast.
anyone have L2 screenshot of this? scottrade is painful
READ HOW MANY WERE CANCELED
n connection with the Exchange Agreement, Bryan Sawarynski, the Principal NGLF Shareholder, holding 69,000,000, or approximately 85%, of the 81,483,250 total issued and outstanding common stock of NGLF, agrees to cancel their ownership of 63,000,000 common shares of NGLF ("Cancellation"). Subsequent to the Cancellation, Mr. Sawarynski will hold 6,000,000 shares of common stock of NGLF.
The Exchange Agreement resulted in a change in control of NGLF, with LLC owning 40,000,000 shares of common stock of NGLF, out of a total of 58,483,250 issued and outstanding shares, after giving effect to the Exchange and Cancellation. Also, Marcus Frasier and Kyle Reilly were elected directors of NGLF and appointed as its executive officers. As a result of the Exchange Agreement, (i) DP became a wholly-owned subsidiary of NGLF and (ii) NGLF succeeded to the business of DP as its sole business. Accordingly, on February 23, 2010, NGLF amended its articles of incorporation in the State of Nevada to change its name from "National Golf Emporium, Inc." to "Idle Media, Inc."
I truly hope you are accurate blue.....
best luck
HAMMER I thought that the super 8-K was going to be out to weeks ago what happened bro?
People be honest when you post stuff please
genius gonna be rich soon
211,000 shares traded today wow. about 2/3 the float.....
Holding all my shares here 10,000 shares at 1.42 average and not intending to sell. This is all a joke. I have seen this type of stuff happen before news comes out....
We shall see I am all or non here very disappointed at the moment......
ALL IMO
Hansen Has News...... Things are starting to move in the right direction
Press release
May 12, 2010, 8:30 a.m. EDT · Recommend · Post:
Hansen Medical Announces FDA Conditional IDE Approval for Evaluating Sensei X Robotic Catheter System for Treatment of Atrial Fibrillation
First Case Completed in Pivotal Clinical Trial
MOUNTAIN VIEW, CA, May 12, 2010 (MARKETWIRE via COMTEX) -- Hansen Medical, Inc. /quotes/comstock/15*!hnsn/quotes/nls/hnsn (HNSN 2.65, +0.15, +6.00%) announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) authorizing a clinical trial to investigate use of the Sensei(R) X Robotic Catheter System and the Artisan(TM) Control Catheter for treatment of Atrial Fibrillation (AF). The first case in the ARTISAN AF Trial, a pivotal clinical trial using the Sensei X system for the treatment of AF, was completed May 11, 2010 by Joseph Gallinghouse, M.D., electrophysiologist, at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center. The Principal Investigator of the trial is Andrea Natale, M.D., F.A.C.C., F.H.R.S., executive medical director for TCAI.
"As an early adopter of the Sensei technology, and an experienced electrophysiologist, I am very pleased to initiate this important study to advance the clinical understanding of this groundbreaking flexible robotic technology in the treatment of arrhythmias," said Dr. Natale.
Atrial Fibrillation, or AF, (the most common cardiac arrhythmia) affects an estimated 3.3 million Americans and 4.5 million Europeans. This number is expected to increase due to an aging population and a rising number of people with chronic heart disease. AF is associated with increased long-term risk for severe and disabling stroke, and it is estimated that 15-20 percent of strokes occur in people with AF(1).
The ARTISAN AF Trial is a prospective, randomized study of the Hansen Medical Sensei X System for introducing and positioning the Biosense Webster NAVISTAR(R) THERMOCOOL(R) Catheter in patients with AF. The trial will enroll patients with symptomatic, drug-refractory paroxysmal AF at a 2:1 ratio and evaluate robotic technique versus manual technique for the ablation of AF. There are two primary endpoints: Safety, defined as the absence of early onset of all major adverse events, and efficacy, defined as freedom from AF through one year. Up to 14 investigative sites worldwide will enroll 300 subjects. The trial protocol recommends that the IntelliSense(R) force sensing system be used to guide ablative lesion placement. The IntelliSense readings of 10-20g during ablation, with a maximum of 40g are recommended. The protocol also recommends that ablation is performed using irrigated radio frequency (RF) power settings of 20-25W with a maximum power of 30W, and a maximum temperature of 50 degrees Celsius. Additionally, data will be collected to compare the reduction in radiation exposure and the potential improvements in single-procedure success rates.
"We are enthusiastic about working closely with the FDA in executing this critical study," said Dan Wallace, co-founder and vice president of regulatory, clinical and advanced applications for Hansen Medical. "We believe this study will enable Hansen Medical to provide important data to clinicians regarding the utility of our technology in ablation of AF. In addition, we are privileged to have strong relationships with world renowned clinical leaders interested in taking part in this study under the guidance of our principal investigator and early visionary, Dr. Andrea Natale."
In order for physicians to participate in the ARTISAN AF Trial, he or she must have previously performed at least 20 procedures with the Sensei system. In addition, they must enroll at least two patients per month as a study investigator, and they need to have performed a minimum of 100 atrial fibrillation ablation procedures manually.
"My colleagues and I have completed more than 385 cases using the Sensei system and we are thrilled to be taking part in this timely and important study," said Dr. Gallinghouse. "In addition to evaluating safety and efficacy, this study design provides us an opportunity to investigate whether less radiation and RF energy is used robotically, compared to what may be typical with manual technique."
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei(R) Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.
Forward-Looking Statements
This press release contains forward-looking statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words "plan," "expects," "believes," "goal," "estimate," and similar words. Hansen Medical intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995.
Hansen Medical, Heart Design, Hansen Medical & Heart Design, Sensei, IntelliSense, and Fine Force Technology are registered trademarks, and Artisan, Artisan Extend, Lynx, CoHesion, and Instinctive Motion are trademarks of Hansen Medical, Inc. in the United States and other countries.
Navistar and ThermoCool are registered trademarks of Biosense Webster.
(1) Source: The American College of Cardiology, the American Heart Association and the European Society of Cardiology.
Media Contact:
Amy Cook
925.552.7893
Email Contact
Investor Contacts:
Peter Osborne
650.404.5800
Email Contact
Lasse Glassen
Financial Relations Board
Email Contact
213.486.654
SOURCE: Hansen Medical, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=92E056D33807F290http://www2.marketwire.com/mw/emailprcntct?id=7A512E45208881B7http://www2.marketwire.com/mw/emailprcntct?id=EEFACC839089E4A7
Yep Not worried about HNSN. The next intuitive surgical. I believe fredric moll was former CEO of intuitive surgical. Things that make you go..
It has been in the 2-2.50 range for quite a while.. About ready to move up In my opinion
Keep in mind all info I post is strictly my opinion and not intended as investment advise
HNSN Just type it in in form4oracle and observe all the insider buying over the last 3 months....
Pretty impressive
I AM PUTTING MY SELL AT 10.00 so no one can mess with my shares
Interestingly one trick to prevent lots of wacko activity from the MM's is for everyone to put in their sell order at around 10.00 or higher. Then there will be no more walking it down balogne. I mean really if the float is really only 350,000 shares I assume that on this board we have quite a significant amount.
Just try anything to beat the MM's at their own game...
Some more info on QTWW note the second to last paragraph
"The eleven Toyota Prius hydrogen hybrid vehicles developed by Quantum, designed to introduce more hydrogen as fuel with which they can be extended to travel miles from the shopneed to refuel. The vehicles are equipped with an electronic developed multi-point hydrogen injection technology from Quantum. The vehicles are also turbocharged and intercooled."
http://autoshybrids.blogspot.com/2010/01/hydrogen-hybrids-delivered-to-norway.html
PLG continues to look strong here...... I think it will continue its move up this week with all the platinum etf news. IT has been lagging all platinum metals stocks
PLG the next SVM IMO
Watch it closely
Thanks to Wealth University for doing lots of edumacation... :)
IF anyone has any thoughts please share
lovin AIB right here blue.
what day excatly do they expect to be fully reporting? Does anyone know? Wasn't the CEO interview suppose to be today?
they way this stock is described it sounds like a nasdaq, or nyse stock
Raven will build, own and operate all of its own plants and will seek equity partners worldwide. Our technology has been tested for commercial operation and allows us to convert cellulosic waste streams (like wood and agriculture waste) into high value ethanol and derivative furfural chemicals.
hmmm lets see where they go with this...
yes lets hope you are not wrong like you were today.
When do we start moving up.. arghhhh hurry up now :) it will come to pass.